Shandong Xinhua Pharmaceutical Company Limited logo

Shandong Xinhua Pharmaceutical Company Limited (000756)

Market Closed
20 Dec, 06:57
XSHE XSHE
¥
16. 39
+0.54
+3.41%
¥
9.08B Market Cap
- P/E Ratio
0.04% Div Yield
18,562,863 Volume
- Eps
¥ 15.85
Previous Close
Day Range
15.81 16.6
Year Range
13.45 20.89
Want to track 000756 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

000756 Chart

Shandong Xinhua Pharmaceutical Company Limited Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
Mr. Tongqing He CEO
XSHE Exchange
CNE000000BG1 ISIN
DE Country
7,104 Employees
- Last Dividend
27 Jul 2018 Last Split
- IPO Date

Overview

Shandong Xinhua Pharmaceutical Company Limited operates as a multifaceted pharmaceutical enterprise within the People's Republic of China and extends its reach globally, including the Americas and Europe. Established in 1943 and headquartered in Zibo, the company commits to the development, manufacturing, and marketing of a vast spectrum of pharmaceutical products. Its subsidiaries play a crucial role in this expansive operation, ensuring the company maintains its reputable position in the pharmaceutical industry. Besides its primary focus on pharmaceuticals, Shandong Xinhua Pharmaceutical Company Limited also diversifies its interests into the real estate sector, showcasing its versatile business model.

Products and Services

Shandong Xinhua Pharmaceutical Company Limited offers an extensive portfolio of products and services across various therapeutic categories:

  • Antipyretic and Analgesic Drugs: These pharmaceuticals are designed to reduce fever and relieve pain. The company's lineup of antipyretic and analgesic drugs caters to the basic healthcare needs, providing essential remedies for common conditions such as headaches, body aches, and fever.
  • Cardiovascular and Cerebrovascular Drugs: Focusing on the heart and blood vessels, this category includes medications aimed at treating conditions related to the cardiovascular and cerebrovascular systems. These drugs are crucial for the management and treatment of diseases such as hypertension, heart attacks, and strokes, thus playing a significant role in prolonging and improving the quality of life for patients with such conditions.
  • Anti-infective Drugs and Central Nervous Drugs: This category encompasses medications used to combat infections and drugs that affect the central nervous system (CNS). Anti-infective drugs include antibiotics, antivirals, antifungals, and antiparasitics, which are essential in fighting a wide range of infections. Central nervous drugs, on the other hand, target the CNS and are used in treating various conditions, including psychiatric disorders, neurodegenerative diseases, and pain management.
  • Other Drugs: Shandong Xinhua Pharmaceutical extends its product range to include other pharmaceuticals that cater to a variety of medical conditions, emphasizing the company's commitment to addressing a broad spectrum of healthcare needs.

In addition to its pharmaceutical products, Shandong Xinhua Pharmaceutical Company Limited engages in the real estate sector, showcasing its versatility by venturing into development projects. This diversification strategy highlights the company's dynamic approach to business, aiming to capture growth opportunities beyond its core pharmaceutical endeavors.

Contact Information

Address: Chemical Industry Area, Zibo, China, 255005
Phone: 86 53 3216 6666